HealthEquity (NASDAQ:HQY - Get Free Report) had its target price decreased by research analysts at KeyCorp from $120.00 to $110.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. KeyCorp's price target would indicate a potential upside of 21.96% from the stock's current price.
HQY has been the subject of several other reports. Barrington Research reiterated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th. JMP Securities boosted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price on the stock. Royal Bank of Canada increased their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. Finally, Wells Fargo & Company boosted their price objective on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and an average target price of $113.31.
View Our Latest Stock Report on HealthEquity
HealthEquity Price Performance
HQY stock traded down $0.13 during trading on Monday, reaching $90.19. 2,054,483 shares of the company were exchanged, compared to its average volume of 698,236. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market capitalization of $7.80 billion, a price-to-earnings ratio of 82.74, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a 50-day moving average of $104.40 and a two-hundred day moving average of $95.94.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.20% of the company's stock.
Institutional Trading of HealthEquity
A number of large investors have recently added to or reduced their stakes in HQY. Ameritas Investment Partners Inc. increased its stake in shares of HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after purchasing an additional 88 shares during the last quarter. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in shares of HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund lifted its position in shares of HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after buying an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System grew its stake in shares of HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after acquiring an additional 100 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.
HealthEquity Company Profile
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.